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To the Editor:
We would like to thank Dr Coudroy and colleagues for their
letter, which gives us the opportunity to clarify some important
points.
First of all, when researchers aim to assess the prognosis value
of a clinical sign or a biological tool, it is crucial to delineate a
precise clinical context. Assessment of mottling prognosis value
perfectly illustrates this point. Mottling is deﬁned as patchy skin
discoloration that usually starts around the knees due to hetero-
genic small vessel vasoconstriction, reﬂecting abnormal skin
microperfusion [1]. More than 45 years ago, mottling was
frequently noticed in patients with septic shock [2]. It has to be
noticed that mottling is a dynamic clinical sign. The time of
assessment may be crucial to deﬁne the mottling prognosis value.
We ﬁrst reported the mottling score and its evolution during
the ﬁrst 24 h in the context of septic shock [3]. We found that,
among hemodynamic parameters collected six hours after vaso-
pressors infusion was started, mottling score was the strongest
predictor of 14-day mortality (OR in univariate analysis: score
0–1: 1, score 2–3: 16, score 4–5: 74, p <0.0001). Moreover,
14-day mortality was different according the mottling score
evolution between H0 and H6 (mortality when mottling score
decrease: 23% vs. mortality when mottling score increase: 88%,
p = 0.0005). This illustrates the crucial importance to deﬁne the
time of mottling assessment. In our study, H6 was chosen
because it is the time to assess the efﬁcacy of the initial hemody-
namic management according to the recommendations of the
Surviving Sepsis Campaign [4].
In another study, we assessed the mottling score during
mechanical ventilation weaning to evaluate its predictive value
on the weaning outcome [5]. We noticed that, during the sponta-
neous breathing trial, mottling could appear and the increase in
the mottling score was predictive of trial failure. Once again,
these results illustrates that mottling is a dynamic sign and that
its prognosis value depends on the clinical context and the time
of its assessment.
In our study recently published in the Journal of Hepatology,
we focused on patients with cirrhosis and septic shock because
we hypothesised that mottling score could have different progno-
sis value in patients with potentially cirrhosis-induced systemic
vasodilation [6]. Similarly than in patients without cirrhosis in
septic shock, mottling score assessed at H6 was the strongest
hemodynamic parameters associated to 14-day mortality and
mottling score evolution between H0 and H6 was strongly asso-
ciated with 14-day mortality. Comparing these results with a
population of 75 non-cirrhotic patients with septic shock, we
highlighted some particularities of mottling in patients with cir-
rhosis. Due to higher skin perfusion in cirrhotic patients, mottling
appearance was delayed in non-survivors and the sensitivity of772 Journal of Hepatology 20
Open access under CC BY-NC-ND license.mottling score to predict 14-day mortality was lower whereas
its speciﬁcity was excellent.
In the study by Coudroy and colleagues, the nurses recorded
the presence of mottling in a non-selected population of ICU
patients [7]. However, quantiﬁcation of mottling and frequency
of skin hypoperfusion recording were not standardized.
Mottling was present at the day on admission in 19% and
occurred later in 10% of included patients. Among patients with
mottling, persistent mottling P6 h was associated with higher
in-ICU mortality (76%, vs. 52%, p = 0.001). In this study, only
32% of patients with mottling received vasopressors at mottling
onset, vasopressors were started and ﬂuid challenge was per-
formed during the mottling episode in 9% and 26% respectively,
and 60% had a mean arterial pressure P65 mmHg without
vasopressors. This result conﬁrms that mottling could occur aside
from the shock context.
Among analyzed patients, 40 had cirrhosis. In their letter,
Coudroy et al. report that 18 of them (45%) had at least one
mottling episode during their ICU-stay. Mottling persisted more
than six hours in 14 patients and four of them (29%) died. In their
letter, the authors seem to be surprised of such a difference of
mortality between their study and ours. However, as detailed
above, mottling is a dynamic sign which can occurred in various
circumstances. Therefore, it is absolutely not surprising that
mottling prognosis value is different aside from the septic shock
context, which still associated with high mortality in patients
with cirrhosis [8]. Generalizing the prognosis value of clinical
signs or biological tools aside its validation context is always
source of error.
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